A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Apotex Europe B.V., Egis Pharmaceuticals PLC, Pfizer, spol. s r.o., against the decision of the State Institute for Drug Control from 24. 3. 2017, under the no. SUKLS27614/2017 - The decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal.
More information: MZCR.cz (czech version only)